Meiyun Liu

1.2k citations
48 papers · 945 indexed · h-index 16
Topics
Monoclonal and Polyclonal Antibodies Research (6 papers)Immune cells in cancer (5 papers)Glycosylation and Glycoproteins Research (4 papers)
Partner nations
ChinaTaiwanTürkiye

In The Last Decade

Meiyun Liu

47 papers receiving 934 citations

Peers

Meiyun Liu
Comparison fields: 5 of 129
  • Molecular Biology 360
  • Pulmonary and Respiratory Medicine 212
  • Immunology 187
  • Cancer Research 129
  • Neurology 71
Replace Pengfei Li with:
Pengfei Li China
Yu Zhong China
Meng Qi China
Giuseppe Palermo Italy
Yanjun Jia China
Marcelo E. Andía Chile
Jinhua Yang China
Jinlong Zhao China
Luming Liu China
Wenhui Liu China
Meiyun Liu relative to Pengfei Li China Pengfei Li's profile →
Citations per field
00.5×1.5×2.5×
Pengfei Li · 1×
Citations per year

Countries citing papers authored by Meiyun Liu

Since Specialization
Citations

This map shows the geographic impact of Meiyun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyun Liu more than expected).

Fields of papers citing papers by Meiyun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiyun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyun Liu. The network helps show where Meiyun Liu may publish in the future.

Co-authorship network of co-authors of Meiyun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Meiyun Liu. A scholar is included among the top collaborators of Meiyun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiyun Liu. Meiyun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 0
4 3
5 36
6 6
7 4
8 14
9 2
10 58
11 13
12 47
13 20
14
Advances on autoimmune antibodies and infertility mechanism of infertility
2
15 3
16 35
17 2
18 12
19 2
20 3

About Meiyun Liu

Meiyun Liu is a scholar working on Anesthesiology and Pain Medicine, Immunology and Cancer Research, having authored 48 papers that have together received 945 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Immune cells in cancer (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Immunology (187 citations), Cancer Research (129 citations) and Pulmonary and Respiratory Medicine (212 citations). Meiyun Liu has collaborated with scholars based in China, Taiwan and Türkiye. Frequent co-authors include Xin Lv, Yuanli Chen, Juan Wei, Hao Yang, Huanping Zhou, Huimin Deng, Lingmin Wu, Xuan Shi, Lina Zhu and Zheng Li. Their work appears in journals such as Journal of Hazardous Materials, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026